← Back to Search

ESOGER for Aging (ESOGER-PC Trial)

N/A
Waitlist Available
Led By Nadia Sourial, PhD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the eq-5d will be measured at study entry (time 0) and at study follow-up (3 months) for both the intervention and control group.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to evaluate the ESOGER telehealth tool, which helps doctors assess the health and social needs of older adults over the phone. The study focuses on patients aged 65 and above, particularly those in rural areas who may have difficulty accessing healthcare. By using ESOGER, doctors can better understand and address their patients' needs, potentially improving their quality of life and autonomy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the eq-5d will be measured at study entry (time 0) and at study follow-up (3 months) for both the intervention and control group.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the eq-5d will be measured at study entry (time 0) and at study follow-up (3 months) for both the intervention and control group. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline quality of life score at 3 months

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Patients 65 years old and older will receive a pre-consultation screening questionnaire by phone prior to their virtual or in-person visit. A summary report based on the results of the questionnaire will be placed in the patient electronic chart for use by the clinician at the time of visit.
Group II: Control GroupActive Control1 Intervention
Usual care in the primary care clinic

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
377 Previous Clinical Trials
131,068 Total Patients Enrolled
Nadia Sourial, PhDPrincipal InvestigatorUniversité de Montréal
~115 spots leftby Nov 2025